IL6 and type 2 diabetes mellitus: Insulin resistance syndrome and type 2 diabetes mellitus are considered as an inflammatory state due to increased production of pro-inflammatory cytokines, such as TNFα and IL-6 [17]; b) motility impairment has been described in diabetic patients showing delayed duodenum-cecal transit time.